Logo Image
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsPeer ExchangeInsightsCase StudiesCase of the QuarterClinical ForumsPractice OwnershipRapid ReadoutShortsVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Andrew Sedgwick

Advertisement

Articles by Andrew Sedgwick

Optometrists and industry leaders alike share exciting new developments in myopia management.

AAOpt 2025 recap: EssilorLuxottica, SightGlass Vision provide updates in myopia

ByAndrew Sedgwick,Jennifer S. Harthan, OD, FAAO, FSLS,Monica Jong, BOptom, PhD,Ryan Parker, OD,Lynda Charters,Jordana Joy, Editor
October 29th 2025

Optometrists and industry leaders alike share exciting new developments in myopia management.

Sedgwick said that with the recent FDA authorization of Stellest lenses, he expects SightGlass to eventually find its niche in the US.

AAOpt 2025: SightGlass Vision CEO Andrew Sedgwick on what's next for DOT spectacle lenses

ByAndrew Sedgwick,Jordana Joy, Editor
October 15th 2025

Sedgwick said that with the recent FDA authorization of Stellest lenses, he expects SightGlass to eventually find its niche in the US.

Advertisement

Latest Updated Articles

  • Sedgwick said that with the recent FDA authorization of Stellest lenses, he expects SightGlass to eventually find its niche in the US.
    AAOpt 2025: SightGlass Vision CEO Andrew Sedgwick on what's next for DOT spectacle lenses

    October 15th 2025



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

What Lytenava FDA approval means for compounded bevacizumab in AMD

2

Remote Area Medical: Lindsay Elkins, OD, FAAO, on care for underserved communities

3

Study: Myopia develops in 1 in 4 nonmyopic male high school students in China

4

WaveDȳn integrates with Bausch + Lomb and WAVE for scleral lens fitting

5

Identifying premyopia and encouraging preventative treatments

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us